Impact of titration, dosing-factor and pulse-width on electroconvulsive therapy remission rates in depression
Julia Meijer(Amsterdam University Medical Centers), Eric van Exel(Amsterdam Neuroscience), Mardien L. Oudega(GGZ inGeest), Esmée Verwijk(Amsterdam University Medical Centers), Joey Verdijk(Rijnstate Hospital), Philip van Eijndhoven(Radboud University Nijmegen), Karina Somers(Parnassia Groep), Annemiek Dols(Utrecht University), J.M. Hegeman(St. Antonius Ziekenhuis), Sigfried Schouws(Amsterdam Neuroscience), Adriaan W. Hoogendoorn(GGD Amsterdam), Rob Kok(Parnassia Groep), Gijsbert Schuur(Rijnstate Hospital), Dore Loef(University Medical Center Utrecht), Jeroen van Waarde(Rijnstate Hospital), Nadine Berkhof(GGZ inGeest), Roel J. T. Mocking(Amsterdam UMC Location University of Amsterdam)
Cited by 1
Related Papers
A prediction model for electroconvulsive therapy effectiveness in patients with major depressive disorder from the Dutch ECT Consortium (DEC)
|Molecular Psychiatry|2024|25
Pre-treatment predictors of cognitive side-effects after treatment with electroconvulsive therapy in patients with depression: A multicenter study
|Journal of Affective Disorders|2024|24
Interrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy Effectiveness
|Biological Psychiatry|2021|23
Electroconvulsive therapy is associated with increased immunoreactivity of neuroplasticity markers in the hippocampus of depressed patients
|Translational Psychiatry|2023|21
The impact of treatment resistance on outcome and course of electroconvulsive therapy in major depressive disorder
|Acta Psychiatrica Scandinavica|2023|17